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Abstract. 
 
Nerve growth factor (NGF) deprivation
induces a Bax-dependent, caspase-dependent pro-
grammed cell death in sympathetic neurons. We
examined whether the release of cytochrome 
 
c 
 
was
accompanied by the loss of mitochondrial membrane 
potential during sympathetic neuronal death. NGF-
deprived, caspase inhibitor–treated mouse sympathetic 
neurons maintained mitochondrial membrane poten-
tial for 25–30 h after releasing cytochrome 
 
c
 
. NGF-
deprived sympathetic neurons became committed to 
die, as measured by the inability of cells to be rescued 
by NGF readdition, at the time of cytochrome 
 
c
 
 release. 
In the presence of caspase inhibitor, however, this com-
mitment to death was extended beyond the point of cy-
tochrome 
 
c
 
 release, but only up to the subsequent point 
of mitochondrial membrane potential loss. Caspase-9 
deﬁciency also arrested NGF-deprived sympathetic 
neurons after release of cytochrome 
 
c
 
, and permitted 
these neurons to be rescued with NGF readdition. 
Commitment to death in the NGF-deprived, caspase-
9–deﬁcient sympathetic neurons was also coincident 
with the loss of mitochondrial membrane potential. 
Thus, caspase inhibition extended commitment to 
death in trophic factor–deprived sympathetic neurons 
and allowed recovery of neurons arrested after the loss 
of cytochrome 
 
c
 
, but not beyond the subsequent loss of 
mitochondrial membrane potential.
Key words: apoptosis • caspase-9 • bax • sympathetic 
neurons • NGF
 
Introduction
 
Extensive programmed cell death (PCD)
 
1
 
 occurs during
neuronal development. Much of this apoptotic death oc-
curs during the developmental period of target innerva-
tion when many neuronal populations are acutely depen-
dent on target-derived trophic factors (Oppenheim, 1991).
Apoptotic cell death is also observed in pathological situa-
tions such as stroke, spinal cord injury, and in certain neu-
rodegenerative diseases (Deshmukh, 1998; Schulz et al.,
1999). Therefore, understanding how neurons undergo
PCD is important for developing rational therapies that
may prevent neuronal death after injury or disease.
The mechanism by which trophic factor deprivation in-
duces PCD in neurons has been extensively studied in
sympathetic neurons that are dependent on NGF for sur-
vival (Deshmukh and Johnson, 1997). In culture, sympa-
thetic neurons deprived of NGF undergo apoptosis within
24–48 h after NGF removal (Martin et al., 1988; Edwards
et al., 1991; Deckwerth and Johnson, 1993; Edwards and
Tolkovsky, 1994). This cell death is dependent on macro-
molecular synthesis (Martin et al., 1988) and Bax function
(Deckwerth et al., 1996), and is prevented by caspase in-
hibitors such as boc-aspartyl(OMe)-fluoromethylketone
(BAF; Deshmukh et al., 1996; Stefanis et al., 1996; Troy et
al., 1996; M.J. McCarthy et al., 1997).
Recent studies have focused on the importance of mito-
chondria during apoptosis because experiments with cell-
free systems have indicated that the release of cytochrome
 
c
 
 from mitochondria represents a critical event during
apoptosis (Liu et al., 1996; Reed, 1997). Data from these
studies are consistent with a model in which Bcl-2 family
proteins modulate the release of cytochrome 
 
c
 
 from the
mitochondria in response to an apoptotic stimulus. Once
in the cytosol, cytochrome 
 
c
 
 presumably binds to Apaf-1
and procaspase-9 and forms a functional apoptosome; the
binding of cytochrome 
 
c
 
 to Apaf-1 and procaspase-9 in the
presence of dATP/ATP is sufficient to promote caspase
activation in cell-free extracts (Liu et al., 1996; Ellerby et
al., 1997; Li et al., 1997). Consistent with this model, Bax
translocates to the mitochondria (Putcha et al., 1999) and
is required for cytochrome 
 
c
 
 release from the mitochon-
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dria (Deshmukh and Johnson, 1998)
 
 
 
before caspase activa-
tion during NGF deprivation–induced sympathetic neu-
ronal death. The cytoplasmic accumulation of cytochrome 
 
c
 
is necessary, but not sufficient, to mediate sympathetic neu-
ronal death (Neame et al., 1998; Deshmukh and Johnson,
1998). NGF deprivation also induces sympathetic neurons
to develop competence-to-die, a macromolecular synthesis-
independent, Bax-independent event, which is required
along with the cytosolic cytochrome 
 
c
 
 to induce apoptosis in
these neurons (Deshmukh and Johnson, 1998).
The exact mechanism by which cytochrome 
 
c
 
 is released
from mitochondria during apoptosis remains unknown.
Bcl-2 family proteins, in particular Bax, may regulate the
formation of a channel in the outer mitochondrial mem-
brane, allowing components of the intermembrane space,
including cytochrome 
 
c
 
, to be released (Schendel et al.,
1998). Alternatively, the release of cytochrome 
 
c
 
 may oc-
cur as a consequence of mitochondrial permeability transi-
tion (MPT), an event in which the mitochondrial inner
membrane becomes permeable to molecules and, as a con-
sequence, the mitochondria become rapidly depolarized.
Mitochondrial matrix swelling and rupture of the outer
mitochondrial membrane would then release cytochrome
 
c
 
 (Crompton, 1999). Indeed, mitochondrial depolariza-
tion, a consequence of MPT, is observed in several models
of apoptosis (Lemasters et al., 1998; Marzo et al., 1998;
Wadia et al., 1998). However, whether the release of cyto-
chrome 
 
c
 
 precedes or follows mitochondrial depolariza-
tion remains controversial, and may depend on the cell
type and the apoptotic stimulus. For example, mitochon-
drial depolarization precedes, or occurs simultaneously,
with cytochrome 
 
c
 
 release in hepatocytes treated with tu-
mor necrosis factor 
 
a
 
 (Bradham et al., 1998) and in PC6
cells treated with 5 
 
m
 
M staurosporine (Heiskanen et al.,
1999). In contrast, the loss of mitochondrial membrane po-
tential occurs after cytochrome 
 
c
 
 release in 1-
 
m
 
M stauro-
sporine- or UV-treated HeLa cells (Yang et al., 1997;
Bossy-Wetzel et al., 1998; Goldstein et al., 2000) and in
etoposide-treated monocytic THP.1 cells (Zhuang et al.,
1998). Similarly, cortical neurons treated with DNA-dam-
aging agents (Stefanis et al., 1999) and hippocampal neu-
rons treated with 300 nM staurosporine (Krohn et al.,
1999) release cytochrome 
 
c
 
 before changes in the mito-
chondrial membrane potential.
Finally, the events that determine when a cell becomes
committed to die during apoptosis remain unclear. Since
the mitochondrial events precede caspase activation in
many models of apoptosis, cells saved by caspase inhibi-
tion may not be able to recover, and may eventually go on
to die because mitochondrial oxidative phosphorylation is
presumably compromised after cytochrome 
 
c
 
 loss (Green
and Kroemer, 1998). Indeed, in mitotic cells induced to
undergo apoptosis, caspase inhibitors block the character-
istic features of apoptosis but not the commitment to
death; the caspase inhibitor–treated cells cannot be res-
cued (lose their ability to form colonies) even if serum is
added back to the cultures (N.J. McCarthy et al., 1997;
Ohta et al., 1997; Amarante et al., 1998; Brunet et al., 1998;
Gibson, 1999). In contrast, NGF-deprived, sympathetic
neurons that are saved with caspase inhibitors are capable
of resuming somal growth (Deshmukh et al., 1996), restor-
ing mitochondrial cytochrome 
 
c
 
 (Martinou et al., 1999),
and regaining electrophysiological function (Werth et al.,
2000) if NGF is added back to the cultures. However, the
window of time afforded by caspase inhibition, during
which rescue with NGF readdition is possible, has not
been examined, and the molecular events that permit res-
cue in these neurons are not known. Answers to both
these points are important to assess the clinical usefulness
of caspase inhibition in a therapeutic context.
In this paper, we examined the events that permit the
NGF-deprived, caspase inhibitor–treated sympathetic neu-
rons to be rescued by readdition of NGF. Specifically, we
asked the following questions. How long can a cell survive
and be capable of rescue with NGF readdition after cyto-
chrome 
 
c
 
 is released? What events ultimately determine
when a cell, treated with caspase inhibitor, becomes com-
mitted to death? We also examined the temporal relation-
ship between the loss of cytochrome 
 
c
 
 and the loss of mito-
chondrial membrane potential after NGF removal. We
found that cytochrome 
 
c
 
 was released before any signifi-
cant changes in mitochondrial membrane potential during
sympathetic neuronal death. Furthermore, the NGF-
deprived sympathetic neurons became committed to die at
the time of cytochrome 
 
c
 
 loss. However, in BAF-treated
or caspase-9–deficient sympathetic neurons, this commit-
ment to death was extended beyond the time of cyto-
chrome 
 
c
 
 release, but only until the point at which the mi-
tochondrial membrane potential was lost. Thus, our data
indicate that caspase inhibition extends the commitment
to death of mouse sympathetic neurons by 25–30 h after
the loss of cytochrome 
 
c
 
, but not beyond the subsequent
loss of mitochondrial membrane potential.
 
Materials and Methods
 
Reagents
 
Mitotracker orange CM-H
 
2
 
TMRos was purchased from Molecular
Probes. Caspase inhibitor BAF was purchased from Enzyme Systems
Products. Collagenase and trypsin were purchased from Worthington Bio-
chemical Corp. All other reagents were purchased from Sigma Chemical
Co., unless otherwise stated. Untimed, pregnant ICR mice were pur-
chased from Harlan Sprague Dawley.
 
Sympathetic Neuronal Cultures
 
Primary cultures of sympathetic neurons from the superior cervical gan-
glion (SCG) neurons were prepared from postnatal-day-1–old (P1) mice,
essentially as described previously for rats (Johnson and Argiro, 1983;
Deshmukh et al., 1996). In brief, the dissected ganglia were treated with
collagenase (1 mg/ml) and trypsin (2.5 mg/ml) for 30 min each at 37
 
8
 
C. The
ganglia were triturated, and the dissociated cells were plated on collagen-
coated dishes in NGF-containing medium (AM50). This medium con-
tained Eagle’s minimum essential medium with Earle’s salts (Life Technol-
ogies Inc.), with the addition of 50 ng/ml 2.5S NGF, 10% FCS, 2 mM
glutamine, 100 
 
m
 
g/ml penicillin, and 100 
 
m
 
g/ml streptomycin; 20 
 
m
 
M fluoro-
deoxyuridine, 20 
 
m
 
M uridine, and 3.3 
 
m
 
g/ml aphidicolin were also included
to reduce the number of nonneuronal cells. ICR outbred mice (Harlan
Sprague Dawley) were used for all experiments except those involving
Bax-deficient and caspase-9–deficient sympathetic neurons. The genetic
background of Bax-deficient and caspase-9–deficient mice was C57BL/6;
wild-type littermates were used as controls in these experiments.
 
Culture Conditions and Assessment of Cell Viability 
after NGF Readdition
 
Sympathetic neuronal cultures were grown in NGF-containing medium
(AM50) for 4–5 d, and then either maintained in AM50 or treated with
various conditions. For NGF deprivation, cultures were rinsed twice with 
Deshmukh et al. 
 
Caspase Inhibition Extends Commitment to Neuronal Death
 
133
 
medium lacking NGF (AM0: AM50 medium without NGF), followed by
addition of AM0 containing goat anti–NGF neutralizing antibody (Ruit et
al., 1990). For NGF deprivation in the presence of cycloheximide or the
caspase inhibitor, 1 
 
m
 
g/ml cycloheximide or 50 
 
m
 
M BAF was added, re-
spectively, to the anti-NGF–containing medium. For rescue experiments
in which NGF was readded to NGF-deprived cultures at various times af-
ter NGF deprivation (maintained in the absence or presence of caspase in-
hibitor BAF), cultures were rinsed three times and incubated in the NGF-
containing medium (AM50) for seven additional days. After 7 d of NGF
readdition, the rescued neurons were clearly identifiable with large and
phase-bright cell bodies, whereas the nonrescued neurons became atro-
phic and appeared degenerated. The number of rescued cells was quanti-
tated after fixing the cultures with 4% paraformaldehyde and staining
with crystal violet as described previously (Deckwerth and Johnson,
1993). Neurons were scored as viable if the crystal violet–positive cells had
large, well-defined cellular outlines. Dead neurons and debris stain faintly
or show no staining with crystal violet.
 
Mitochondrial Membrane Potential and
Cytochrome c Staining
 
To assess the status of the mitochondrial membrane potential and cyto-
chrome 
 
c
 
 in individual cells, sympathetic neurons were loaded with Mi-
totracker orange and immunostained with cytochrome 
 
c
 
 antibodies. Sym-
pathetic neurons that were maintained for 4–5 d in NGF-containing
medium were first treated with various conditions and loaded with 1 
 
m
 
M
Mitotracker orange (freshly prepared in DMSO) in the appropriate cul-
ture medium for 1 h at 37
 
8
 
C in the dark. We found that loading cells with
Mitotracker orange before subjecting cells to various experimental condi-
tions was not a reliable method of assessing the mitochondrial membrane
potential in sympathetic neurons. For the NGF deprivation experiments,
50 
 
m
 
M BAF was included in the culture medium to eliminate any cell loss
that would otherwise affect the quantitation; no BAF was added when the
caspase-9–deficient cells were analyzed in this assay. Cells were washed
four times with PBS and fixed in freshly prepared 4% paraformaldehyde
for 30 min at 4
 
8
 
C. After three washes in TBS (100 mM Tris-HCl, pH 7.6,
and 0.9% NaCl), the cultures were processed for cytochrome 
 
c
 
 immuno-
histochemistry as described previously (Deshmukh and Johnson, 1998).
Anti–cytochrome 
 
c
 
 antibody (PharMingen) was used at a final concentra-
tion of 0.5 
 
m
 
g/ml and an anti-mouse Alexa 488–conjugated secondary anti-
body (Molecular Probes) was used at a final concentration of 2 
 
m
 
g/ml. Nu-
clei were stained with Hoechst 33258 (Molecular Probes) as described
previously (Deshmukh and Johnson, 1998). The status of the mitochon-
drial membrane potential and cytochrome 
 
c
 
 staining in sympathetic neu-
rons was quantitated by visualizing the cells with a Zeiss Axiophot micro-
scope. Cells were first visualized on the basis of their nuclear staining, and
then scored as positive or negative for Mitotracker orange and cyto-
chrome 
 
c
 
 staining by a naive observer. Only cells that had completely lost
all punctate staining were scored as negative.
 
Mitotracker Staining and NGF Rescue in
Sympathetic Neurons
 
The status of Mitotracker orange staining and rescue with NGF readdition
in cultures of sympathetic neurons was examined as follows. Sympathetic
neuronal cultures were maintained in NGF-containing medium for 5 d,
and were deprived of NGF in the presence of 50 
 
m
 
M BAF for 60 h. This
time corresponded to the point at which almost all cells had lost cyto-
chrome 
 
c
 
 staining, and about half the cells had lost their Mitotracker stain-
ing. Cells were loaded with Mitotracker by incubating in the same me-
dium containing 250 nM Mitotracker orange (prepared freshly in DMSO)
for 1 h at 37
 
8
 
C. Care was taken to ensure minimum exposure of cultures to
light in all subsequent manipulations (particularly while taking photo-
graphs) because exposure to intense light was found to be toxic to the Mi-
totracker-labeled cells. The Mitotracker concentration that was used in
these rescue experiments (250 nM) was lower than that used in the previ-
ous immunostaining experiments (1 
 
m
 
M) to minimize phototoxicity. Since
no immunostaining steps with washes were involved in these rescue exper-
iments, the lower Mitotracker concentration was found to be sufficient to
provide an adequate signal. After the labeling period, cells were washed
four times and incubated in NGF-containing medium. Representative
fields of cells (marked from a reference point; day 0 [d0] after NGF res-
cue) were photographed under phase-contrast microscopy to visualize the
cells and under fluorescence microscopy to visualize Mitotracker staining
(Fuji Provia film, ASA 1600). Cells were returned to the 37
 
8
 
C incubator,
 
and phase-contrast photographs of the same fields of cells were taken at
d2, d4, and d7 after the NGF readdition. For quantitation, the phase-con-
trast photographs of cells at d0 after NGF rescue were first projected onto
a screen and individual cells were numbered. The Mitotracker staining
status of these cells was scored as positive or negative. The phase-contrast
photographs of the same field of cells at d2, d4, and d7 after NGF rescue
were compared to determine which cells were rescued; rescue was defined
by the ability of these cells to increase somal diameter after NGF readdi-
tion. Only cells whose rescue fate was clearly identifiable were counted.
Approximately 200 cells were scored per experiment.
 
Bax
 
2
 
/
 
2
 
 and Caspase-9
 
2
 
/
 
2
 
 Mice
 
Breeding and genotyping of Bax-deficient mice has been described previ-
ously (Knudson et al., 1995; Deckwerth et al., 1996). Bax-deficient sympa-
thetic neurons were isolated from postnatal-1-d-old mice. Breeding and
genotyping of caspase-9–deficient mice was performed as described pre-
viously (Kuida et al., 1998). Caspase-9–deficient sympathetic neurons
were isolated from embryonic 17-d-old mice; these cultures were main-
tained in NGF-containing medium for 6–7 d (instead of the normal 4–5 d)
before subjecting them to various experimental conditions.
 
Results
 
Use of Mitotracker Orange as an Indicator of 
Mitochondrial Membrane Potential in
Sympathetic Neurons
 
To examine the temporal relationship between cytochrome
 
c
 
 release and the mitochondrial membrane potential loss
in sympathetic neurons after NGF deprivation, cells were
loaded with Mitotracker orange and subjected to cyto-
chrome 
 
c
 
 immunocytochemistry. Mitotracker orange is a
mitochondrial membrane potential–sensitive dye that is
aldehyde fixable and, therefore, compatible with subse-
quent immunocytochemical analysis (Poot et al., 1996;
Matylevitch et al., 1998). This allowed us to assess the sta-
tus of mitochondrial membrane potential and localization
of cytochrome 
 
c
 
 simultaneously in individual cells under-
going apoptosis.
NGF-maintained sympathetic neurons loaded with Mi-
totracker orange showed a punctate staining pattern iden-
tical to that of the mitochondria-localized cytochrome 
 
c
 
(Fig. 1). To confirm that Mitotracker orange was an indi-
cator of mitochondrial membrane potential in sympathetic
neurons, we examined Mitotracker staining after treat-
ment with agents that disrupt the mitochondrial mem-
brane potential. NGF-maintained sympathetic neurons
were treated with carbonyl cyanide m-chlorophenylhy-
drazone (CCCP) or valinomycin, uncouplers of oxidative
phosphorylation (Chen, 1988), for 2 h, and then were
loaded with Mitotracker orange. Treatment with CCCP
or valinomycin reduced dramatically or eliminated Mi-
totracker staining in sympathetic neurons in a dose-depen-
dent manner (Fig. 1 and Table I). The Mitotracker-loaded
cells were also immunostained for cytochrome 
 
c
 
 to assess
the localization of cytochrome 
 
c
 
 after such treatments. Cy-
tochrome 
 
c
 
 immunostaining remained largely unaffected
with CCCP or valinomycin despite the loss of Mitotracker
staining, at least during the period examined (Fig. 1 and
Table I). Treatment of sympathetic neurons for 2 h with
agents that disrupt the plasma membrane potential such as
KCl or ouabain (Chen, 1988) did not affect either Mi-
totracker or cytochrome 
 
c
 
 staining (Fig. 1 and Table I).
Thus, Mitotracker orange appeared to be a reliable indica- 
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tor of mitochondrial membrane potential in sympathetic
neurons.
An important point to note is that, in these and subse-
quent experiments, sympathetic neurons were loaded with
Mitotracker orange after treatment with various condi-
tions. Loading cells with Mitotracker orange before treat-
ment with CCCP did not result in decreased Mitotracker
staining after disruption of the mitochondrial membrane
potential (data not shown). Thus, although the uptake of
the Mitotracker dye was sensitive to mitochondrial mem-
brane potential, once the Mitotracker dye was taken up by
the mitochondria, its signal did not decrease reliably under
conditions that disrupted the mitochondrial membrane
potential.
 
Loss of the Mitochondrial Membrane Potential during 
Sympathetic Neuronal Death Requires Upstream 
Events that Are Dependent on Macromolecular 
Synthesis and Bax Function
 
NGF deprivation induces a series of events that result in
the loss of cytochrome 
 
c
 
 from mitochondria during sympa-
thetic neuronal death. Inhibition of protein synthesis with
cycloheximide addition or Bax deficiency blocks the path-
way leading to the release of cytochrome 
 
c
 
, whereas
caspase inhibition does not (Neame et al., 1998; Desh-
mukh and Johnson, 1998; Martinou et al., 1999; Putcha et
al., 1999). To determine whether sympathetic neurons also
lose mitochondrial membrane potential after NGF depri-
vation, we examined the status of the mitochondrial mem-
brane potential in NGF-deprived sympathetic neurons;
BAF was added to the medium in these experiments to
prevent any cell death after NGF deprivation that would
otherwise complicate quantitation of results caused by a
loss of neurons from the population. The status of the
mitochondrial membrane potential and cytochrome 
 
c
 
staining in individual sympathetic neurons undergoing
apoptosis was assessed by using Mitotracker orange and
cytochrome 
 
c
 
 immunostaining as described above.
Staining for both cytochrome 
 
c
 
 and Mitotracker in
NGF-maintained sympathetic neurons appeared punctate,
as expected for their mitochondrial localization (Fig. 2;
 
1
 
NGF). NGF deprivation for 72 h resulted in the loss of
both cytochrome 
 
c
 
 and Mitotracker staining in most cells,
indicating that cells had released cytochrome 
 
c
 
 and lost
their mitochondrial membrane potential (Fig. 2; 
 
2
 
NGF/
 
1
 
BAF). We examined whether the loss of mitochondrial
membrane potential seen with NGF deprivation was de-
Figure 1. Validation of Mitotracker
orange staining as an indicator of
mitochondrial membrane potential
in sympathetic neurons. Shown are
representative photomicrographs of
sympathetic neurons that were ei-
ther untreated (NGF) or treated
with CCCP (100 mM), KCl (100
mM), or ouabain (100 mM) for 2 h in
the presence of NGF. Neurons were
loaded with Mitotracker orange (1
mM for 1 h), and subsequently pro-
cessed for cytochrome c immun-
ostaining. Cytochrome c immun-
ostaining and Mitotracker signal for
the same cells is shown; staining
with Hoechst 33258 shows the corre-
sponding nuclei of these cells. Bar,
15 mm.
 
Table I. Quantitation of Cytochrome c and Mitotracker 
Staining in Sympathetic Neurons Treated with
Various Conditions 
 
Percent total 
cytochrome 
 
c
 
1
 
Percent total 
Mitotracker
 
1
 
1
 
NGF
(untreated) 100 100
 
1
 
CCCP 
10 
 
m
 
M
100 
 
m
 
M
100
100
98 
 
6
 
 2
0
 
1
 
Valinomycin
10 
 
m
 
M
100 
 
m
 
M
100
100
0
0
 
1
 
KCl 100 mM 100 100
 
1
 
Ouabain
10 
 
m
 
M
100 
 
m
 
M
100
100
100
99 
 
6
 
 1
 
The number of cells showing intact mitochondrial cytochrome 
 
c
 
 and Mitotracker
staining after treatment with various condition (Fig. 1) is shown as a percentage of total
number of cells examined. Cells were considered to be negative for cytochrome 
 
c
 
 or
Mitotracker only if the characteristic punctate staining pattern was lost completely.
Results are mean 
 
6 
 
range of two independent experiments with 100–200 cells counted
for each condition. 
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pendent on events requiring macromolecular synthesis
or Bax expression. NGF-deprived, cycloheximide-treated
sympathetic neurons maintained both cytochrome 
 
c and
Mitotracker staining even after 72 h of NGF deprivation
(Fig. 2; 2NGF/1CHX). Likewise, sympathetic neurons
from Bax-deficient mice showed intact cytochrome c and
Mitotracker staining even after 72 h of NGF deprivation
(Fig. 2; 2NGF/Bax2/2). These results suggest that a com-
mon, macromolecular synthesis–dependent, Bax-depen-
dent pathway leads to the release of cytochrome c and loss
of mitochondrial membrane potential during NGF depri-
vation–induced sympathetic neuronal death.
Release of Cytochrome c Precedes the Loss of 
Mitochondrial Membrane Potential during Sympathetic 
Neuronal Apoptosis
To understand the mechanism of cytochrome c release
during sympathetic neuronal death, we examined whether
the loss of cytochrome c preceded or followed the loss of
mitochondrial membrane potential in individual sympa-
thetic neurons undergoing apoptosis after NGF depriva-
tion. Sympathetic neurons were deprived of NGF, and at
various times after NGF deprivation, the cells were loaded
with Mitotracker orange and processed for cytochrome c
immunostaining. The status of cytochrome c and Mi-
totracker staining in individual sympathetic neurons was
determined, and the results were grouped into four possi-
ble categories: (1) cells that maintained both cytochrome c
and Mitotracker staining (CytC1 MitoT1); (2) cells that
lost cytochrome c but maintained Mitotracker staining
(CytC2 MitoT1); (3) cells that maintained cytochrome c
but lost Mitotracker staining (CytC1 MitoT2); and (4)
cells that lost both cytochrome c and Mitotracker staining
(CytC2 MitoT2). Examples of cells that were seen in
these categories are shown in Fig. 3 A. Note that no CytC1
MitoT2 cells were observed during NGF deprivation–
induced cell death (see below).
All NGF-maintained sympathetic neurons had intact cy-
tochrome c and Mitotracker staining (Fig. 3 B; 0 h). Upon
NGF deprivation, this population of cells decreased gradu-
ally, such that by 24 h after NGF removal, only 50% of
cells were CytC1 MitoT1 and, by 120 h after NGF re-
moval, none of the cells had intact cytochrome c or Mi-
totracker staining (Fig. 3 B). Conversely, the population of
cells that had lost both cytochrome c and Mitotracker
staining increased gradually after NGF removal and by
120 h after NGF removal, all cells were CytC2 MitoT2.
We also observed a transient increase in the population of
cells that had lost cytochrome c but still maintained Mi-
totracker staining (CytC2 MitoT1) after NGF removal.
More important however, we did not observe any cells
that maintained cytochrome c, but lost Mitotracker stain-
ing (CytC1 MitoT2) at any time point after NGF depriva-
tion (Fig. 3 B). Since we observed cells that were CytC2
MitoT1 but never cells that were CytC1 MitoT2 after
NGF deprivation, our data indicate that individual sympa-
thetic neurons first released cytochrome c and subse-
quently lost mitochondrial membrane potential.
The time course of the loss of cytochrome c and the loss
of mitochondrial membrane potential in NGF-deprived,
BAF-treated sympathetic neurons (data taken from Fig. 3
B) is shown in Fig. 3 C. Consistent with our previous re-
sults, 50% percent of the mouse (ICR) sympathetic neu-
rons released cytochrome c by 24 h after NGF removal
(Deshmukh and Johnson, 1998). In contrast, Mitotracker
staining was not lost in 50% of the NGF-deprived, BAF-
saved sympathetic neurons until 55–60 h after NGF re-
moval (Fig. 3 C). Thus, the NGF-deprived, BAF-saved
sympathetic neurons were able to maintain a mitochon-
Figure 2. Loss of mitochondrial
membrane potential during sympa-
thetic neuronal death requires up-
stream events that are dependent on
macromolecular synthesis and Bax
expression. Shown are representa-
tive photomicrographs of sympa-
thetic neurons either maintained in
NGF (1NGF) or deprived of NGF
for 72 h either in the presence of
1  mg/ml cycloheximide (2NGF/
1CHX) or 50 mM BAF (2NGF/
1BAF). Also shown are Bax-defi-
cient sympathetic neurons that were
deprived of NGF for 72 h (2NGF/
Bax2/2). Neurons were loaded with
1 mM Mitotracker orange for 1 h
and processed for cytochrome c im-
munostaining. Cytochrome c immu-
nostaining and Mitotracker signal
for the same cells, and the corre-
sponding nuclei labeled with Hoechst
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drial membrane potential for z30 h after release of cyto-
chrome c. As discussed above, these experiments were
done in the presence of caspase inhibitor. Without caspase
inhibition, mitochondrial depolarization presumably fol-
lows the loss of cytochrome c relatively rapidly, since cells
activate caspases and become committed to die soon after
releasing cytochrome c (see below).
Caspase Inhibition Allows Sympathetic Neurons to 
Recover after Cytochrome c Release, but Not Beyond 
the Subsequent Loss of Mitochondrial
Membrane Potential
Recent studies indicate that NGF-deprived, BAF-treated
sympathetic neurons that have released cytochrome c are
capable of recovering with subsequent NGF readdition
(Deshmukh et al., 1996; Martinou et al., 1999; Werth et al.,
2000). However, whether caspase inhibition permits this
neuronal rescue with NGF readdition indefinitely has not
been examined. Since the recovery of cells that have been
saved by caspase inhibition is important from a therapeu-
tic perspective, we wanted to determine how long caspase
inhibition could extend the commitment to death in these
cells.
NGF-maintained sympathetic neurons were deprived of
NGF either in the absence or presence of the caspase in-
hibitor BAF. At various times after NGF deprivation,
NGF was added back to the cultures and the neurons were
allowed to recover for 7 d. The number of surviving cells
after this 7-d rescue period was quantitated. This long-
term rescue assay was needed to determine unambigu-
ously whether caspase inhibition extended the commit-
ment to death. Examples of BAF-saved sympathetic
neurons that were rescued with NGF readdition are shown
in Fig. 4 A. Control cells deprived of NGF for 72 h without
any BAF show extensive cell death (Fig. 4 A; 2NGF 72
hr). Caspase inhibition with BAF addition blocks cell
death in these neurons. Note that all seven cells marked in
the 2NGF 1 BAF condition appear saved at 72 h by the
criterion of being phase-bright. However, after 7 d of NGF
readdition, only three of the seven cells in that field were
able to be recovered with NGF (Fig. 4 A; NGF rescue 7 d).
Figure 3. Time course of loss of cytochrome c and mitochondrial membrane potential during NGF deprivation–induced sympathetic
neuronal death. NGF-maintained sympathetic neurons (5 d in vitro) were deprived of NGF in the presence of 50 mM BAF. At various
times after NGF removal, cultures were loaded with Mitotracker orange (1 mM for 1 h) and immunostained for cytochrome c. The cyto-
chrome c and Mitotracker status of individual cells were quantitated by a naive observer. Results are grouped in four possible out-
comes: cells maintaining cytochrome c and Mitotracker staining (CytC1 MitoT1); cells that lost cytochrome c but maintained Mi-
totracker staining (CytC– MitoT1); cells that maintained cytochrome c but lost Mitotracker staining (CytC1 MitoT–); or cells that lost
both cytochrome c and Mitotracker staining (CytC– MitoT–). (A) Examples of cells found in these states at various times after NGF re-
moval are shown. Each column of pictures represents one field of neurons. CytC1 MitoT1 (circles); CytC– MitoT1 (squares); and
CytC– MitoT– (triangles). No CytC1 MitoT– cells were found at any time after NGF deprivation. (B) Quantitation of data showing the
percentage of cells displaying the various states of cytochrome c and Mitotracker staining at the indicated times after NGF deprivation.
(C) Data from B are replotted to show the time course of loss of cytochrome c and Mitotracker staining at the indicated times after
NGF deprivation. Results are mean 6 SEM from at least three independent experiments with z100–200 cells counted for each time
point. Bar, 20 mm.Deshmukh et al. Caspase Inhibition Extends Commitment to Neuronal Death 137
Thus, after 7 d of NGF rescue, it was possible to distin-
guish unequivocally between those cells that were rescued
with NGF readdition (cells 2, 5, and 6), and those cells that
had already become committed to die and were not able to
recover with NGF readdition (cells 1, 3, 4, and 7).
Using this NGF rescue assay, we determined the per-
centage of cells that became committed to die at various
times after NGF deprivation, either in the absence or pres-
ence of BAF. The rescue data (Fig. 4 B) were compared
with the time course of loss of cytochrome c and Mi-
totracker staining (from Fig. 3 C) since internally con-
trolled parallel cultures that were deprived of NGF at the
same time were used in both these assays. Without BAF
addition, 50% of mouse sympathetic neurons became
committed to die by z25 h after NGF deprivation (Fig. 4
B). The time course of commitment after NGF depriva-
tion is almost identical to the time course of the loss of cy-
tochrome c (Fig. 4 B). BAF addition extended the com-
mitment of sympathetic neuronal death by z25–30 h. 50%
of the NGF-deprived, BAF-saved sympathetic neurons
became committed to die by 55–60 h of NGF deprivation
(Fig. 4 B). Remarkably, the time course of commitment to
death in the presence of caspase inhibitor was indistin-
guishable from the time course of loss of Mitotracker
staining, which marks the loss of mitochondrial membrane
potential in these neurons (Fig. 4 B). We define commit-
ment to death in the absence of caspase inhibitor as Com-
mitment 1 (coincident with cytochrome c release) and
commitment to death in the presence of caspase inhibitor
as Commitment 2 (coincident with mitochondrial mem-
brane potential loss).
Mitotracker Staining Predicts Rescue with NGF 
Readdition in Individual Sympathetic Neurons 
Undergoing Apoptosis
The population-based study shown above demonstrates a
good correlation between loss of Mitotracker staining and
failure to be rescued with NGF readdition (Fig. 4). To test
further the hypothesis that loss of mitochondrial mem-
brane potential marks the commitment to death in caspase
inhibitor–treated neurons (Commitment 2), we examined
whether the correlation between the maintenance of mito-
chondrial membrane potential and rescue with NGF read-
dition could also be seen in individual sympathetic neu-
rons undergoing apoptosis. Sympathetic neurons were
deprived of NGF in the presence of BAF for 60 h (2.5 d).
NGF deprivation for 60 h corresponds to a time when
.90% of cells had lost cytochrome c and z50% of cells
had lost Mitotracker staining (Fig. 3 C). Cells were loaded
with Mitotracker orange (250 nM for 1 h) and photo-
graphed to document which cells had lost or maintained
Mitotracker staining (Fig. 5 A, 2NGF 1 BAF 2.5 d). As
expected, z50% of cells had lost Mitotracker staining at
that time (data not shown). NGF was added to the cul-
tures, and the neurons were allowed to recover for 7 d.
Figure 4. Time course of commitment to death in NGF-deprived sympathetic neurons in the absence or presence of caspase inhibitor.
(A) Phase-contrast photographs showing sympathetic neurons rescued with NGF readdition. Representative field of NGF-deprived,
BAF-treated cells (72 h of NGF deprivation, 50 mM BAF) showing seven neurons (numbered 1–7) that are prevented from undergoing
apoptosis (left; 2NGF 1 BAF 72 h). The same field of cells is shown 7 d after NGF readdition (right; NGF rescue 7d). Cells numbered
2, 5, and 6 were rescued with NGF, whereas cells numbered 1, 3, 4, and 7 were not. Top panels show photographs of control cells that
were either maintained in NGF (1NGF) or deprived of NGF without BAF for 72 h (2NGF 72 h). (B) Data showing the percentage of
sympathetic neurons capable of recovery with NGF readdition. NGF-maintained mouse sympathetic neurons (5 d in vitro) were de-
prived of NGF either in the absence (open circles) or presence of 50 mM BAF (open squares). At the indicated times after NGF depri-
vation, NGF was added back to the cultures for 7 d. The number of NGF-rescued cells was quantitated by crystal violet staining and
counting all stained cells in the culture dish. Data showing time course of loss of cytochrome c and Mitotracker staining are taken from
Fig. 3 C. Results are mean 6 SEM of at least three independent experiments. Bar, 20 mm.The Journal of Cell Biology, Volume 150, 2000 138
Phase-contrast photographs of the identical field were
taken at 2, 4, and 7 d after NGF readdition to follow the
status of individual sympathetic neurons (Fig. 5 A; 1NGF
rescue d2, d4, and d7). More than 90% of the cells that
were Mitotracker-positive were rescued with NGF readdi-
tion (Fig. 5 B), in contrast to ,15% of the Mitotracker-
negative cells that were capable of rescue with NGF read-
dition (Fig. 5 B). The photograph in Fig. 5 A show examples
of the correlation seen between Mitotracker staining and
rescue with NGF addition. In the field shown, all Mi-
totracker-positive cells (4 out of 10 cells, numbered 1–4)
were rescued with NGF readdition, whereas the Mi-
totracker-negative cells were not (Fig. 5 A).
Caspase-9–deficient Sympathetic Neurons Are Arrested 
after the Loss of Cytochrome c and Can Be Rescued 
with NGF Readdition
One prediction from our results is that any genetic manip-
ulation that arrests NGF-deprived sympathetic neurons
after the release of cytochrome c would allow these neu-
rons to be rescued with NGF readdition but only until
the point of loss of mitochondrial membrane potential.
We tested this prediction on sympathetic neurons from
caspase-9–deficient mice. We chose to examine caspase-
9–deficient sympathetic neurons because caspase-9 is
thought to be the apical caspase that becomes activated
once cytochrome c is released from mitochondria (Li et
al., 1997). Moreover, caspase-9 appears important for neu-
ronal death in vivo since most caspase-9–deficient mice,
which die perinatally, have a markedly enlarged brain
that is caused by reduced apoptosis during development
(Hakem et al., 1998; Kuida et al., 1998).
Sympathetic neurons from caspase-9–deficient mice
were deprived of NGF for 72 h to determine first the effect
of caspase-9 deletion on sympathetic neuronal death. Cul-
tures from the wild-type littermates were examined in par-
allel. Caspase-9–deficient neurons appeared phase-bright
and had intact neurites even after 72 h of NGF depriva-
tion, whereas those from wild-type littermates appeared
degenerated and dead at this time (Fig. 6 A). These results
indicate that caspase-9 deficiency prevented sympathetic
neurons from undergoing apoptosis after NGF depriva-
tion. The NGF-deprived, caspase-92/2 neurons appeared
atrophic presumably because these neurons, like the NGF-
deprived, BAF-saved neurons are arrested after the meta-
bolic changes that occur after NGF removal (Deshmukh
et al., 1996). Similar neuroprotection was also observed in
caspase-3–deficient sympathetic neurons deprived of NGF
(data not shown).
We next examined whether the NGF-deprived, caspase-
9–deficient sympathetic neurons were capable of being
rescued with NGF readdition. Caspase-92/2 neurons were
deprived of NGF and, at various times after NGF depriva-
tion, NGF was added back for 7 d to assess the number of
rescued neurons. Cultures from wild-type littermates were
examined in parallel. The status of cytochrome c and Mi-
totracker staining in caspase-92/2 neurons was also ex-
amined in parallel at identical times after NGF depriva-
tion. Caspase-9 deficiency inhibited sympathetic neuronal
death after the point of cytochrome c release; virtually all
caspase-9–deficient cells had lost cytochrome c by 24 h af-
ter NGF deprivation (Fig. 6 B). Cytochrome c release in
these cells is complete by 24 h, as reported previously
for this genetic background (C57BL/6) (Putcha et al.,
1999). NGF-deprived, BAF-saved sympathetic neurons
from wild-type littermates of caspase-9–deficient mice also
released cytochrome c by 24 h after NGF deprivation
(data not shown).
Consistent with the time course of cytochrome c loss,
.95% of wild-type sympathetic neurons were committed
to die (i.e., could not be rescued with NGF readdition) by
24 h after NGF deprivation (Fig. 6 B). In contrast, at that
time, . 80% of caspase-9–deficient sympathetic neurons
were capable of rescue with NGF readdition (Fig. 6 B).
Thus, caspase-92/2 sympathetic neurons were arrested at a
point after the loss of cytochrome c and could be rescued
be with NGF readdition. Longer periods of NGF depriva-
Figure 5. Mitotracker staining predicts rescue with NGF readdition. (A) NGF-maintained sympathetic neurons were deprived of NGF
in the presence of 50 mM BAF for 60 h (2.5 d). Cells were loaded with Mitotracker orange (250 nM for 1 h) and photographed to docu-
ment the status of Mitotracker staining in cells. A representative field shows 4 cells out of 10 that were Mitotracker positive (numbered
1–4; arrow points to one MitoT1 cell). Cells were then treated with NGF, and the same field of cells were photographed after 2, 4, and
7 d of NGF readdition. Photographs show that the Mitotracker positive cells were rescued with NGF readdition, whereas the Mi-
totracker negative cells were not (arrowhead shows one MitoT– cell). (B) Data showing the correlation between Mitotracker positivity
and the ability of cells to be rescued with NGF readdition. Cells were treated as described in A. Results are mean (6 range) of two in-
dependent experiments with z200 cells counted per experiment. Bar, 20 mm.Deshmukh et al. Caspase Inhibition Extends Commitment to Neuronal Death 139
tion resulted in the rescue of fewer caspase-9–deficient
cells. 50% of caspase-9–deficient sympathetic neurons
were not capable of recovery by 50 h of NGF deprivation,
and none were capable of rescue after 5 d of NGF depriva-
tion (Fig. 6 B). As predicted from our data with BAF (Fig.
4), the time course of commitment to death of caspase-
9–deficient sympathetic neurons was found to be similar to
the time course of loss of Mitotracker staining in these
neurons (Fig. 6 B). 
Discussion
In this study, we examined the molecular events that de-
termine when sympathetic neurons become committed to
die after trophic factor withdrawal. We asked whether
caspase inhibition, which inhibits NGF deprivation–
induced apoptosis after release of cytochrome c, extends
the commitment to death and examined what events might
ultimately commit the caspase inhibitor-treated neurons
to die. Three main conclusions from this study are as fol-
lows. First, NGF-deprived sympathetic neurons released
cytochrome c before loss of mitochondrial membrane
potential. The NGF-deprived, BAF-treated sympathetic
neurons maintained the mitochondrial membrane poten-
tial 25–30 h after release of cytochrome c. Second, NGF-
deprived sympathetic neurons became committed to die at
the time of cytochrome c loss (defined as Commitment 1).
Third, in the presence of a caspase inhibitor or in caspase-
9–deficient sympathetic neurons, this commitment point
of death was extended beyond cytochrome c release but
only until the later point of loss of mitochondrial mem-
brane potential (defined as Commitment 2). Once cells
lost mitochondrial membrane potential, they were no
longer capable of recovery with NGF readdition. Thus,
caspase inhibition allowed NGF-deprived sympathetic
neurons to recover with NGF readdition after cytochrome
c release but not beyond the subsequent loss of mitochon-
drial membrane potential.
Cytochrome c Release Precedes the Loss of the 
Mitochondrial Membrane Potential during Sympathetic 
Neuronal Apoptosis
NGF deprivation induces the loss of cytochrome c, before
caspase activation, during sympathetic neuronal death
(Deshmukh and Johnson, 1998; Neame et al., 1998; Marti-
nou et al., 1999; Putcha et al., 1999). We examined the
temporal relationship between cytochrome c release and
loss of mitochondrial membrane potential during sympa-
thetic neuronal apoptosis. 50% of the NGF-deprived,
BAF-saved sympathetic neurons lost cytochrome c by 24 h
after NGF removal, whereas 50% of these neurons did not
lose Mitotracker staining nearly 55 h after NGF removal
(Fig. 3 C). Our observation that a loss of cytochrome c
preceded mitochondrial depolarization in NGF-deprived
sympathetic neurons is consistent with similar reports in
other cell types (Kluck et al., 1997; Yang et al., 1997;
Bossy-Wetzel et al., 1998; Zhuang et al., 1998; Goldstein et
al., 2000), including hippocampal (Krohn et al., 1999) and
cortical (Stefanis et al., 1999) neurons undergoing apopto-
sis. Neame et al. (1998) also report NGF-deprived sympa-
thetic neurons release cytochrome c but still maintain
Mitotracker staining. These results argue against the in-
volvement of MPT as a mechanism for releasing cyto-
chrome c during NGF deprivation–induced sympathetic
neuronal death. Consistent with this, mitochondrial swell-
ing, expected with MPT, is not observed in sympathetic
neurons undergoing apoptosis after NGF deprivation
(Martin et al., 1988; Martinou et al., 1999). Also, mito-
chondria isolated from the brain are more resistant to
Ca21-induced MPT than are mitochondria isolated from
the liver (Andreyev and Fiskum, 1999). Therefore, whether
MPT is required for releasing cytochrome c during apop-
tosis may depend on the specific cell type and the apop-
totic signal.
We cannot exclude the possibility that subtle changes
in mitochondrial membrane potential undetectable with
Mitotracker may have occurred during the release of
Figure 6. Caspase-9 is required for sympa-
thetic neuronal death after NGF deprivation.
(A) Sympathetic neurons from caspase-91/1
(wild-type) and caspase-92/2 (knockout)
mice (littermates) were deprived of NGF for
72 h. Photographs show that, whereas wild-
type neurons degenerated and died by this
time (Caspase-91/1,  2NGF 72 hr), the
caspase-9–deficient neurons were alive and
appeared phase-bright (Caspase-92/2, 2NGF
72 hr). (B) Time course of loss of cytochrome
c (closed circles) and mitochondrial mem-
brane potential (closed squares) in caspase-
92/2 sympathetic neuronal cultures at the indi-
cated times after NGF deprivation. Also
shown are survival data after NGF rescue for
caspase-91/1 (open circles) or caspase-92/2
(open squares) sympathetic neurons. Sympathetic neurons from caspase-91/1 (wild-type) and caspase-92/2 (knockout) mice (litter-
mates) were deprived of NGF and, at the indicated times, NGF was readded to the cultures for 7 d. Rescue experiments were done in
parallel with the cytochrome c and Mitotracker experiments. Results for the cytochrome c and Mitotracker experiments are mean 6
SEM of two to three independent experiments with z100–200 cells counted for each time point. Results for the rescue experiments are
mean 6 SEM of two to three independent experiments with all surviving cells counted for each time point.The Journal of Cell Biology, Volume 150, 2000 140
cytochrome c in sympathetic neurons. Although several
reagents are available for measuring mitochondrial mem-
brane potential, a lack of consensus exists regarding which
is the best reagent to use on intact cells (Bernardi et al.,
1999). We used Mitotracker orange in our studies because
it allowed us to assess mitochondrial membrane potential
and cytochrome c localization simultaneously in individual
cells undergoing apoptosis. Control experiments indicated
that the uptake of Mitotracker was dependent on the mi-
tochondrial membrane potential in sympathetic neurons
(Fig. 1 and Table I). Also, the time course of the loss of
Mitotracker staining was similar to that of the loss of tet-
ramethylrhodamine methyl ester staining, another mito-
chondrial membrane potential–sensitive dye, in NGF-
deprived sympathetic neurons (Deshmukh, M., unpublished
observations).
How are NGF-deprived sympathetic neurons able to
maintain their mitochondrial membrane potential after cy-
tochrome c release? One possibility is that glycolytic path-
ways may generate enough ATP, such that mitochondrial
membrane potential can be maintained by reversal of the
F0F1-ATPase. For example, r2 cells that lack mitochon-
drial DNA use glycolytic ATP to maintain mitochondrial
membrane potential (Skowronek et al., 1992; Marchetti et
al., 1996). Alternatively, a small amount of cytochrome c,
which is undetectable by immunocytochemistry, may still
be present in the mitochondria of the NGF-deprived,
BAF-saved neurons and may be sufficient to maintain
electron transport. HeLa cells can maintain a mitochon-
drial membrane potential even after the loss of cyto-
chrome c because of residual electron transport activity
(Goldstein et al., 2000). Nevertheless, the ability of sympa-
thetic neurons to maintain mitochondrial membrane po-
tential for 25–30 h with no detectable cytochrome c and
without any trophic support is remarkable. Whether post-
mitotic cells like sympathetic neurons engage novel ATP-
generating pathways to survive during periods of cellular
stress such as those described here is unknown.
Loss of Mitochondrial Membrane Potential Marks the 
Commitment to Death in the Caspase Inhibitor–saved 
Sympathetic Neurons
We have used the criterion of NGF rescue (the ability to
respond to NGF readdition with an increase in somal di-
ameter) to demonstrate that caspase inhibition extended
the commitment to death in NGF-deprived sympathetic
neurons from the point of cytochrome c release to the
later point of mitochondrial depolarization (Fig. 4). This
study extends previous observations showing that NGF-
deprived, BAF-saved sympathetic neurons are capable of
increasing somal diameter (Deshmukh et al., 1996) and re-
storing cytochrome c in mitochondria (Martinou et al.,
1999) with NGF readdition. BAF-saved neurons that are
rescued with NGF readdition appear to have normal func-
tion since their electrophysiological properties are indis-
tinguishable from those of NGF-maintained sympathetic
neurons (Werth et al., 2000).
The ability of NGF-deprived, BAF-saved sympathetic
neurons to be rescued with NGF readdition correlated
well with their ability to maintain a mitochondrial mem-
brane potential after cytochrome c release (Fig. 4). This
correlation held remarkably well, even in individual sym-
pathetic neurons (Fig. 5). These results are consistent with
the hypothesis that once cells lose their ability to generate
sufficient ATP to maintain their mitochondrial membrane
potential, they can no longer be rescued with NGF readdi-
tion.
The NGF-deprived, BAF-treated sympathetic neurons
that could not be rescued with NGF readdition eventually
died without exhibiting any characteristics of apoptosis.
For example, dying cells did not immunostain with CM1
antibodies that label active caspase-3 (Srinivasan et al.,
1998), nor did they display the typical pattern of annexin V
or TUNEL staining (data not shown). Since most apop-
totic characteristics in dying cells are likely a consequence
of caspase activation (Samali et al., 1999), death occurring
in the presence of caspase inhibitors is not expected to dis-
play the same apoptotic characteristics. For example, cere-
bellar granule neurons or cortical neurons, which normally
undergo an apoptotic death with caspase activation in re-
sponse to various insults, undergo a delayed nonapoptotic
cell death when caspase inhibitors are added (Miller et
al., 1997; Stefanis et al., 1999). Likewise, caspase-9– or
caspase-3–deficient cells exhibit few apoptotic features
when undergoing cell death (Hakem et al., 1998; Kuida et
al., 1998; Woo et al., 1998; Cregan et al., 1999; D’Mello et
al., 2000).
Caspase-9 Is Required for Sympathetic Neuronal Death
Our results show that caspase-9 is important in mediat-
ing sympathetic neuronal death (Fig. 6). NGF-deprived,
caspase-9–deficient sympathetic neurons were capable of
rescue with NGF readdition even after the point of cyto-
chrome c loss. As with the BAF-treated cells, the even-
tual commitment to death in the NGF-deprived, caspase-
9–deficient sympathetic neurons also correlated with the
loss of mitochondrial membrane potential (Fig. 6 B). The
observation that caspase-9 deficiency or BAF addition
provided similar neuroprotection in NGF-deprived sym-
pathetic neurons suggests that caspase-9 is the critical api-
cal caspase activated in these cells once cytochrome c is re-
leased from the mitochondria. Fig. 7 depicts our current
model of the sympathetic neuronal death pathway after
NGF deprivation.
What Criteria May Permit Rescue of Cells Arrested 
after Release of Cytochrome c
The ability of caspase inhibitors to keep postmitotic sym-
pathetic neurons alive and capable of rescue with NGF re-
addition contrasts with the results in primary fibroblasts
and several cell lines in which caspase inhibition merely
changes the phenotype of death but ultimately has no ef-
fect on the commitment to death. Specifically, caspase in-
hibition did not allow these mitotic cells to maintain clono-
genecity even with serum readdition (N.J. McCarthy et al.,
1997; Ohta et al., 1997; Amarante et al., 1998; Brunet et al.,
1998; Gibson, 1999). One explanation for this difference
may be that mitotic cells may not be able to generate suffi-
cient ATP and maintain their mitochondrial membrane
potential for the period after cytochrome c release that
may be required for recovery. Rescue in mitotic cells, as
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arguably require more ATP than rescue in postmitotic
sympathetic neurons. However, recovery after cytochrome
c release may not depend solely on whether a cell is mi-
totic or postmitotic. Hsp70 overexpression blocks tumor
necrosis factor–induced cell death after cytochrome c re-
lease in murine fibrosarcoma cells, yet the Hsp70-overex-
pressing cells appear capable of normal growth in culture
in the presence of the tumor necrosis factor (Jaattela et al.,
1998). However, whether individual cells that have released
cytochrome c are able to recover and resume growth in
these Hsp70-overexpressing cells is unclear.
Alternatively, mitochondrial sequestered, death-promot-
ing proteins, such as AIF, that are released along with
cytochrome c (Lorenzo et al., 1999) may mediate caspase-
independent death in some cells. Since Commitment 2 in
NGF-deprived, BAF-treated sympathetic neurons corre-
lated remarkably well with the loss of Mitotracker stain-
ing, factors such as AIF either may not contribute to sym-
pathetic neuronal death or may become activated only
with complete loss of mitochondrial membrane potential
in these cells. Kluck et al. (1999) report identifying a cyto-
solic activity in Xenopus extracts that causes permeabiliza-
tion of the outer mitochondrial membrane. Whether such
an activity contributes to the eventual loss of mitochon-
drial membrane potential in NGF-deprived, BAF-treated
sympathetic neurons is not known.
The time by which commitment to death is extended
with caspase inhibition (time between Commitment 1 and
Commitment 2) varies not only among different cell types,
but also among different species for the same cell type. For
example, rat sympathetic neurons lose cytochrome c in
50% of neurons by 22–24 h after NGF removal. Yet,
.50% of NGF-deprived, BAF-treated rat sympathetic
neurons are rescued with NGF readdition, even after 4 d
of NGF removal (Deshmukh and Johnson, 2000). Thus,
rat sympathetic neurons are capable of rescue with NGF
readdition for z72 h after cytochrome c release, in con-
trast to a period of z30 h in mouse sympathetic neurons
(Fig. 4). Whether differences in cell sizes of sympathetic
neurons from rat versus mouse contribute to the window
of time between Commitment 1 and Commitment 2 is un-
clear. Consistent with this hypothesis, the survival of
mouse cerebellar granule neurons, which are much smaller
than sympathetic neurons, is extended for only a few hours
after potassium deprivation with caspase inhibition (Miller
et al., 1997; D’Mello et al., 2000).
From a therapeutic perspective, the ability of caspase in-
hibition to promote survival (Figs. 4 and 6) and functional
recovery (Werth et al., 2000) of NGF-deprived sympa-
thetic neurons is very encouraging. Strategies aimed at in-
creasing the time between Commitment 1 and Commit-
ment 2 in neurons may represent means to enhance the
neuroprotective effect of caspase inhibitors. Ultimately,
whether a caspase inhibitor–treated cell survives the re-
lease of cytochrome c and is capable of being rescued may
depend on several factors. First, its ability to withstand po-
tentially toxic factors, which may be released along with
cytochrome c from the mitochondria. Second, its ability to
generate ATP, even after cytochrome c loss and in the
continued presence of an apoptotic stimulus; and third, its
energetic requirements for recovering and maintaining
normal physiological functions.
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